22 results on '"Puerta, J."'
Search Results
2. LATIN-AMERICAN SYSTEMIC LUPUS ERYTHEMATOSUS CLUSTERS.
3. HOME INFUSION CHEMOTHERAPY TREATMENT FOR PATIENTS WITH MALIGNANT HAEMATOLOGICAL DISORDERS.
4. ANALYSIS OF THE IMPLEMENTATION OF A MULTIDISCIPLINARY PHARMACEUTICAL CARE PROJECT FOR GERIATRIC HAEMATO-ONCOLOGY PATIENTS.
5. EXPERIENCE AND PRELIMINARY DATA IN IMPLEMENTATION OF PRO (PATIENT REPORTED OUTCOME) IN THE DAILY ROUTINE IN INFLAMMATORY ARTHRITIS PATIENTS BASED IN ICHOM-ARTHRITIS MODEL AND A NEW ELECTRONIC PLATFORM (QÜESTCLINIC).
6. EVALUATION OF SATISFACTION AND EFFICACY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN DAILY CLINICAL PRACTICE.
7. PLASMA NETS LEVELS IN ESTABLISHED RHEUMATOID ARTHRITIS PATIENTS RECEIVING BIOLOGICAL OR JAK INHIBITOR THERAPY AND ASSOCIATION WITH DISEASE ACTIVITY.
8. CAPISAS PROJECT: INCIDENCE AND EPIDEMIOLOGY OF ANTISINTETASE SYNDROME IN CATALONIA (SPAIN) BETWEEN 2016 AND 2019.
9. SYNOVIAL TISSUE FEATURES ASSOCIATED WITH POOR PROGNOSIS IN INFLAMMATORY ARTHRITIS.
10. ULTRASOUND SYNOVITIS AND NEUTROPHILIC ACTIVITY MARKERS (PLASMA CALPROTECTIN AND NEUTROPHIL EXTRACELLULAR TRAPS) IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING BIOLOGICAL OR JAK INHIBITORS.
11. DIAGNOSTIC AND PROGNOSTIC ROLE OF SERUM KL-6 IN RHEUMATOID ARTHRITIS.ASSOCIATED INTERSTITIAL LUNG DISEASE.
12. LONG-TERM CLINICAL PROFILE OF FILGOTINIB (FIL) IN PATIENTS (PTS) WITH RHEUMATOID ARTHRITIS (RA) BY CARDIOVASCULAR (CV) RISK FACTORS: A POST HOC SUBGROUP ANALYSIS.
13. PREDICTORS OF FIRST HOSPITALIZATIONS DUE TO DISEASE ACTIVITY AND INFECTIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS.
14. RISK OF DEMYELINATING EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TUMOUR NECROSIS FACTOR INHIBITORS: A SYSTEMATIC LITERATURE REVIEW.
15. DIFFERENCES IN THE ASSESSMENT OF COMORBIDITIES (FATIGUE AND DEPRESSION) BETWEEN RA PATIENTS AND PHYSICIANS. DO WE MEASURE THE SAME?
16. The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients.
17. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome.
18. Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients.
19. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients.
20. Prevalence of the antiphospholipid syndrome in primary systemic vasculitis.
21. Coeliac disease associated with systemic sclerosis.
22. Etanercept is effective in patients with rheumatoid arthritis with no response to infliximab therapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.